World Journal of
Pharmaceutical and Life Sciences

OVERVIEW ON CORONAVIRUS DISEASE 2019(COVID-19): IT’S PROGNOSTIC FACTORS; PSYCHOSOCIAL IMPACT AND CURRENT TREATMENT

R. Priyanka*, M. Vishwanath Swamy and V. Ajith Kumar

ABSTRACT

COVID-19 pandemic is threatening all over the world with the emergence and it?s rapid spread. This virus begun as an outbreak in Wuhan, china in December 2019. As of 13th July 2020, there have been 13 million confirmed cases of COVID-19 globally with 5.7 lakhs deaths. Symptoms include mild to severe which worsens the patient condition that may leads to death. Some prognostic factors like diabetes, hypertension, age, sex, weather conditions and smoking are influencing the rapid rate of spread and progression of COVID-19. Diagnosis is done through molecular tests on respiratory samples. Currently there is no vaccine and approved medication, only investigational treatments are suggested like azithromycine, hydroxychloroquine, remdesivir, ribavarin, interferon, corticosteroids, umifevir, inhibitor vitamin-C and vitamin-D. World health organisation (WHO) declares that the preventive and supportive measures are the only strategy to reduce and control this pandemic. The WHO has issued specific psychosocial considerations for abating the growing stigma of COVID-19.

[Full Text Article]   [Download Certificate]